Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, LIC, TRI

ProofPilot and Verified Clinical Trials Announce Strategic Partnership to Scale Participant Integrity in Clinical Trial Recruitment


NEW YORK, March 19, 2024 /PRNewswire/ -- ProofPilot, the industry's only platform for clinical trial automation, guidance and flawless execution, is excited to announce its strategic partnership with Verified Clinical Trials (VCT), the world's leading validated research participant registry and verification platform. This collaboration marks a significant milestone in improving data integrity by reducing the risk of ineligible patients.

VCT facilitates the verification of research participants, reducing risk of duplicate patients in studies. With a commitment to participant protection and data integrity, VCT enhances the reliability of clinical trial data in a way no one else can.

ProofPilot's innovative platform simplifies study conduct by automating clinical tasks, enabling study knowledge management, and eliminating the confusion born from technology proliferation. VCT's integration into ProofPilot simplifies the ability of sites to ensure the integrity of participant eligibility.

"Our goal is to give sponsors the best chance at proving the safety and efficacy of their drugs through workflow automation," says Chris Venezia, CEO of ProofPilot. "With VCT, we will streamline the sites' ability to ensure the right patient is enrolled in trials."

"At VCT, our mission is to safeguard patient safety and data integrity in clinical trials," says Mitchell Efros, CEO & Co-Founder of VCT. "Our partnership with ProofPilot expands this capability for more sponsors by enabling sites to more easily ensure patient data quality throughout the trial process."

Together, ProofPilot and VCT will drive unprecedented advancements in data quality, ultimately benefiting patients, sponsors, and all research stakeholders.

About ProofPilot

Founded in 2014, ProofPilot enables flawless execution of research with the industry's only platform for clinical trial automation, guidance and knowledge management. The platform orchestrates stakeholder tasks and technology, eliminating guesswork, reducing protocol deviations at the site and optimizing the overall patient experience. ProofPilot delivers this capability through Site and Patient Co-Pilot packages. To learn more, visit https://www.proofpilot.com/.

About Verified Clinical Trials

Verified Clinical Trials is the world's leading research participant registry, dedicated to preventing cross-sponsor duplicate entries and protocol deviations in clinical trials. Leveraging advanced participant verification solutions, VCT enhances recruitment efficiency, safeguards data integrity, and fosters trust among stakeholders in clinical research.

Media Contact: Colleen Yang, [email protected]

SOURCE ProofPilot


These press releases may also interest you

at 17:21
Community Healthcare Trust Incorporated (the "Company") today announced the release of its inaugural Corporate Sustainability Report for the year 2023. This comprehensive report highlights the Company's commitment to environmental stewardship,...

at 17:14
BJC HealthCare, one of the largest nonprofit health care organizations in the United States, and Encompass Health , the nation's largest owner and operator of inpatient rehabilitation hospitals, announce the opening of The Rehabilitation Institute of...

at 17:04
Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced a global agreement with the Unsecured Creditors Committee representing the interests of the Company's...

at 17:00
Eupraxia Pharmaceuticals...

at 16:47
Nystrom & Associates, a leading provider of behavioral health care services, today celebrated the expansion of its Hugo, Minn. clinic. The expansion will almost double the clinic's size and will enable more providers to meet the community's mental...

at 16:35
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that registration is open for the two-day virtual public meeting, "FDA's Fifth Online Controlled Substances...



News published on and distributed by: